Tom Bell describes to Wall Street some of the company's "seed corn" investments that will inform how it develops the North Star vision he often speaks of.
The Gryphon Scientific team uses artificial intelligence in their efforts to help agencies detect and respond to infectious diseases, among other biological and chemical threats.
Anduril and General Atomics are well known in the defense industry. But their selections for phase one of the Collaborative Combat Aircraft program stand out for who they went up against and where the tech is going.
One delivery to the U.S.' neighbors up north is on contract and as CACI's chief executive told Wall Street, more activity like that drives the addressable market for its technology.
Technology makers and integrators alike all have to invest in artificial intelligence even as "people are careful and they think properly" about AI's path forward, as GD's chief executive described to investors.
Science Applications International Corp.'s CEO and chief innovation officer started their new jobs on the same day and spoke with investors together to detail where the company wants to go.
